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Abstract
The history of active worldwide scientific research on mechanisms of aging and 
the age-associated diseases counts more than five decades. Of these, among the 
numerous theories of aging, at least 50 years dominated the free radical theory of 
aging. Since mitochondria were found to be the major producers of free radicals, 
the research on aging became largely centered on mitochondria. At the end of 80s 
of the 20th century, physicians have established a new nosological entity named 
“Metabolic syndrome” comprising several simultaneously existing symptoms 
and risk factors, which increase with age to 47% in men and 64% for women. The 
diagnosis of metabolic syndrome (MetS) requires simultaneous presence of at least 
three out of five medical conditions: visceral obesity, hypertension, high blood 
sugar, insulin resistance, low serum high-density lipoprotein accompanied with high 
serum triglycerides. However, from the beginning of the definition of MetS there 
was, and still is, a rather lovely debate, which of the symptoms must be considered 
as the main one. In spite of the enormous number of publications on both mecha-
nisms of aging and MetS, there was relatively small progress in understanding 
the fundamental processes in these closely related problems. On the contrary, the 
mitochondrial free radical theory was found to be wrong in its current paradigms. 
In this Chapter we will discuss recent discoveries and hypotheses which open new 
perspectives in both theoretical and practical approaches to the problems of aging 
and MetS. We will show how aging and development of MetS are closely related to 
each other and the normal ontogenesis of human beings. Why men and women have 
different rates of aging and mechanisms of transition to MetS. We state that MetS 
is not just a cluster of symptoms, but one of the last steps of individual ontogenesis, 
namely the first step of eldership when the aging rate may increase manifold.
Keywords: aging, eldership, energy metabolism, fatty acid oxidation, isoprostane 
lipid peroxidation, mitochondrial DNA, metabolic syndrome, obesity, ontogenesis, 
oxidative stress, perhydroxyl radical, reactive oxygen species, ROS, superoxide 
radical, type 2 diabetes
1. Introduction
Everybody wants to live a long and healthy life. However, the universal laws of the 
Irreversible Thermodynamics drive changes in our bodies from the moment of birth, 
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when a human baby has maximum information in his genes and minimum entropy 
in his body, through a series of consecutive changes to the last stage, when a human 
body has much less information left in the remaining old genes and maximum 
entropy in his body, which finally fails and the person dies.
We intentionally started our Chapter by mentioning the genetically predeter-
mined stages of development of the human organism because, as it happened, 
the concept of ontogeny was somehow lost during the decades of research on 
mechanisms of aging and metabolic syndrome. As we will see, this approach gives 
completely different perspectives on the problems from the point of view of normal 
postembryonic ontogenesis.
The problems of aging and life longevity are not just medical problems, but are 
complex of fundamental biological problems, which comprise evolution, ontogen-
esis, genetics, epigenetics, and interactions with the environment. For this reasons, 
researchers studied aging and longevity starting from simple organisms like yeast and 
worms, then more complex laboratory animals, and even species like crocodiles and 
birds. Humans are, probably, much less studied in this respect than, say, mice and rats. 
To this day there are dozens of aging theories, which reflect the complexity of the prob-
lem. We mention only few of the relatively recent theories of aging: The heterochroma-
tin loss model [1, 2]; adult stem cell and mesenchymal progenitor theory [3]; hormonal 
regulation of longevity in mammals [4]; telomere hypothesis of aging [5, 6]; epigenetic 
theory [7], and finally, currently the most popular and experimentally developed the 
free radical hypothesis of aging [8–21]. All theories of aging and longevity are interre-
lated, but so far, there is no generalizing theory. Therefore, we will start our discussions 
on human aging mechanisms from the currently most important theory of aging: the 
mitochondrial free radical theory.
2. The mitochondrial free radical theory of aging (MFRTA)
Initially proposed by Harman [8], the “Free Radical Hypothesis of Aging” 
was later transformed to the “Mitochondrial Free Radical Theory of Aging” 
(MFRTA), because mitochondria were found to be the main source of free 
radicals [9–14, 19, 22]. Collectively, the free radicals derived from oxygen were 
named “reactive oxygen species” (ROS).
In order to understand the logic of the worldwide research on aging develop-
ment, it would be useful to look back on the intellectual and scientific background 
existing 40–50 years ago. After discovery that mitochondria generate oxygen radi-
cals [23, 24], there was an excitement in finding the “universal mechanism” of all 
diseases. Therefore, for a long-time research on biological effects of ROS was titled 
“oxidative stress”, of which aging was only one of many damaging effects of ROS. 
For some time, it was not realized that organs and tissues age at different pace, and 
that environmental conditions, such as radiation, air contamination or industrial 
pollutants may contribute to the aging process.
Importantly, for a long time any clear-cut specific markers of systemic aging 
were not known, except mutations of mitochondrial DNA (mtDNA). There is a 
strong parallelism between production of ROS and mutations of mtDNA  
[13, 14, 25]. Until recently, this parallelism was explained by a belief that hundreds 
of “naked” circular mtDNA molecules lie in the mitochondrial matrix and thus 
mtDNA is an easy target for free radicals. The accumulation in cells of mtDNA 
damaged by ROS progressively inactivates the DNA templates necessary to repair 
damaged mitochondria. As a result, the accumulation of mtDNA mutations acts as 
the aging clock [25].
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Understandably, mutations of mtDNA became one of the most important 
factors in explaining mechanisms of aging, age-associated diseases and practically 
most major human diseases [25–29]. Only recently it was discovered that mtDNA 
are protected by the proteinaceous “shield”, nucleoids, and that there is no proof for 
the free radical direct effects on mtDNA [30–33].
Production of ROS occurs not only in organs and tissues, but also in blood 
cells where radicals evidently have functions different from those in parenchymal 
cells. The “respiratory burst” of phagocytic cells, when they come in contact with 
bacteria or immune complexes, is important source of superoxide radicals (O2
•). 
Phagocytic cells include neutrophils, monocytes, macrophages and eosinophils 
known to produce large amounts of O2
• [34].
In some cells, particularly in hepatocytes, the major source of ROS may be of 
extramitochondrial origin [35]. In the liver, both O2
• and H2O2 are produced dur-
ing metabolism of xenobiotics by the microsomal P-450-monoxygenases [36], 
and in the course of catabolism of purine nucleotides and nucleosides by xanthine 
oxidoreductase [37]. Liver peroxisomes also produce large amounts of hydrogen 
peroxide during catabolism of very long chain fatty acids and polyunsaturated 
fatty acids [38]. However, in the liver both mitochondria and peroxisomes possess 
high catalase activity, which neutralizes hydrogen peroxide [38, 39]. In addition to 
catalase and superoxide dismutase (isoforms 1 and 2) high activities, liver has high 
activities of glutathione S-transferase (GST) and glutathione peroxidase [40, 41], 
and Prohibitin-1 [42], which enhance the liver’s antioxidant system. For this reason, 
liver is relatively protected from deleterious effects of ROS, has high regenera-
tive capacity [43] and, therefore, the rate of aging of this organ is much slower, as 
compared with other organs [44, 45]. Kidneys also rarely create problems for elderly 
people because they work constantly at a relatively even pace. In the actively work-
ing organs production of ROS is minimal [21]. The fastest rates of aging occur in 
those organs, which have a wide range of workloads, such as skeletal muscles, brain 
and heart. These organs have very high capacities in respiratory activity and ATP 
production to satisfy the organ’s energy demands at high workloads. These organs 
usually have increased ROS production at lower workloads or at rest [21].
Thus, aging is not an evenly distributed over the body process. In addition, 
mechanisms of aging are distinct in different organs and tissues, and the causing 
aging oxidants in various organs and tissues can also be different. In order to clarify 
the last statement and for the sake of the following discussion on the shortcuts 
of the current paradigm of the MFRTA, we give a brief description of the major 
biological and environmental radicals and biologically active molecules.
2.1 Superoxide radical (O2
•) and hydrogen peroxide (H2O2)
Superoxide radical (O2
•) and hydrogen peroxide (H2O2) are quantitatively the 
main species of ROS that are produced constantly by the mitochondrial respiratory 
chain [21, 22]. Superoxide radicals serve also as a source for other ROS: hydroperoxyl 
radical, peroxynitrite, lipid radicals. The proportion of H2O2, produced at the sites 
of the respiratory chain is small [21], but the superoxide in many tissues rapidly 
dismutate to hydrogen peroxide by very high activities of superoxide dismutases in 
the cytosol (Cu,Zn-SOD1) and mitochondrial matrix (Mn-SOD2) [22, 46]. At the 
beginning of the mitochondrial free radical theory, superoxide radical was regarded 
as very dangerous [34]. However, soon it was realized that after O2
• leaves the mem-
brane’s lipid phase, small and negatively charged superoxide anion instantly acquires 
the hydration shell and thus loses most of its chemical activity [47]. In addition, due 
to the high activities of SOD1 and SOD2, present at micromolar concentrations, the 
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superoxide radical half-life is very short (milliseconds) [22]. For this reason attention 
was shifted to other radicals, which can be formed from the superoxide and hydro-
gen peroxide. Nevertheless, O2
• can directly damage enzymes, which contain 4Fe-4S 
clusters by knocking out one Fe2+ atom and turning the 4Fe-4S cluster to inactive 
3Fe-4S. A typical enzyme is aconitase, which is sensitive to inhibition by superoxide.
2.2 Hydroxyl radical (•OH)
Hydrogen peroxide (H2O2), which by itself is a rather harmless chemical, in the 
presence of transition metal ions Fe2+ and Cu1+ produces highly aggressive hydroxyl 
radical (•OH) [34]. However, •OH is so active that it instantly reacts with any mol-
ecule it encounters (except water). For this reason •OH half-life is only 10−9 sec [48] 
and under normal conditions it is not as harmful as initially believed. This radical is 
dangerous when formed in very large quantities, such as after exposure to radiation, 
or high concentration of H2O2 and transition metal poisoning. The latter situation 
is often observed in the experiments in vitro, but hardly takes place in vivo, since 
transition metals in the cells are always chelated.
2.3 Nitric oxide (•NO) and peroxynitrite (OONO−)
Tissues, such as blood vessels endothelium, neurons and others, which possess 
tissue-specific nitric oxide synthases (eNOS), produce a free radical nitric oxide 
(•NO), an important cellular signaling molecule involved in many physiological and 
pathological processes. Formation of one molecule of •NO requires two molecules 
of O2, and since the 
•NO half-life in vivo is about 7 sec., for the maintenance of 
a steady-state concentration of •NO at 1 μM, the consumption of oxygen is very 
high, about 120 nanomol O2 per 1 gram of tissue per1 minute [49]. For this reason, 
the physiologically sufficient steady state levels of •NO can be formed only in the 
oxygen rich cells, like vascular endothelium, or well vascularized organs like brain. 
•NO is a powerful vasodilator. The biological effects of •NO can be inhibited due to 
its fast reaction with superoxide radical yielding a rather toxic product peroxynitrite 
(OONO−) [50]. Peroxynitrite is a strong oxidant and nitrating agent, it interacts 
with lipids, DNA, and proteins via direct oxidative reactions or via indirect, radical-
mediated mechanisms. In vivo, peroxynitrite generation represents an important 
pathogenic mechanism in conditions such as stroke, myocardial infarction, chronic 
heart failure, diabetes, circulatory shock, chronic inflammatory diseases, cancer, 
and neurodegenerative disorders [49, 51]. Peroxynitrite plays an important role in 
pathologies and aging of some organs and tissues, such as blood vessels and neu-
rons, but being a rather strong anion, it hardly contributes to the systemic mecha-
nism of aging, which we will discuss a little later. Nitric oxide is hydrophobic, but 
chemically weak radical, and, thus, also can be excluded from the systemic aging 
mechanism, which occur in the lipid phase of the inner mitochondrial membrane.
At this point, we have not discussed the protonated form of superoxide radical 
(O2
•), namely hydroperoxyl radical (•HO2) because it will be done in conjunctions 
with the description of polyunsaturated fatty acids (PUFA) autoxidation, named 
“Isoprostane Pathway of Lipid Peroxidation” (IPLP), which we propose as the main 
mechanism of aging in people with Metabolic syndrome.
2.4 Environmental biologically active molecules and radicals
Unlike the above described ROS, which are formed in the body and relatively 
well-studied, the biological effects of sun radiation and air pollutants involving 
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singlet oxygen and ozone are less known. However, they are the major causes of 
accelerated aging of skin and lung epithelium. For this reason, we provide a brief 
description of toxic effects of these ROS.
2.4.1 Singlet oxygen
Singlet oxygen is the common name for the two metastable states of molecu-
lar oxygen, but the singlet O2
1Δg is the most active in biological systems. It has 
no unpaired electrons and therefore is not a radical, but upon excitation, one of 
the O2 electrons shifts to a higher and unstable orbit, which makes it chemically 
more active than regular triplet O2. In vivo O2 to O2
1Δg excitation occurs when 
the sunlight fells on human skin containing several biological pigments, such 
as porphyrins or flavins. This is the reason of early skin aging and skin damages 
in people with abnormal porphyrin metabolism. Formation of singlet O2 by 
sunlight occurs also in vivo in both lens and retina of the mammalian eye, which 
causes cataract and loss of vision [52]. Thus, wearing dark glasses and a hat, even 
in not very bright weather, will protect eyes from cataracts early development 
and skin from early aging. Studies of plants suggested that in photosynthetic 
systems one of the functions of polyenes and carotenoids is to protect plants 
from damages caused by singlet oxygen. Therefore, a carrot salad dressed with 
vegetable oil may have protective effect against complications caused by bright 
sunlight.
2.4.2 Ozone (O3)
Ozone (O3) is an allotrope of oxygen and is much less stable than normal O2. 
It forms under the influence of ultraviolet light and during atmospheric electri-
cal discharges (lightning). Even at low concentrations ozone causes damages to 
respiratory tracts of experimental animals and organic materials, such as latex and 
various types of plastic. The ozone’s half-life depends on temperature, humidity 
and air circulation. In a closed room with running fan, ozone’s half-life is about 
24 hours [53]. That is, in a laboratory room, an instrument, like spectrophotometer 
or spectrophluorometer without special device for burning ozone (for example, 
instruments from Perkin Elmer), after several hours of work may create a concen-
tration of ozone high enough to cause a headache and errors in experimental results 
due to accumulation of peroxides in water solutions.
2.4.3 Nitrogen dioxide (•NO2)
For the human’s health it is important that in industrial areas with chemical 
factories and coal power stations the air may be polluted with nitrogen dioxide that 
may damage skin and respiratory organs. •NO2 induces oxidation, as well as cell’s 
membrane proteins nitration. Nitrated biological products, for example, tyrosine-
containing proteins and nitrolipids are often found in the body. It is likely, that •NO2 
has been involved in the formation of these products [54].
2.4.4 Peroxynitrates
Nitrogen dioxide quickly reacts with other radicals. This is one of nitrotyrosines 
formation important mechanisms. During reaction •NO2 + O2
• → O2NOO
• very 
rapidly forms peroxynitrate: It contributes to skin and lung damage mechanisms 
during their contact with air polluted with nitrogen dioxide [54].
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3. Crisis of the mitochondrial free radical theory of aging (MFRTA)
From the described above different free radicals and environmental pollut-
ants, we see that all of them have the potential ability to cause damages to cellular 
and mitochondrial functions, although by different mechanisms. Some of the 
biologically active molecules and radicals show clear tissue and organ specifici-
ties. For example, singlet oxygen damages predominantly skin and eyes; ozone 
and nitrogen dioxide - lung epithelium, nitric oxide and peroxynitrite - vascular 
endothelium and neuronal cells. However, none of the above ROS is directly 
related, with the exception of the superoxide radical, to the inevitable aging 
mechanism [55].
After decades of research a vast amount of accumulated knowledge revealed 
serious inconsistencies between the data obtained and the MFRTA, which call into 
question the correctness of the free radical theory in its current paradigms. We refer 
the reader to excellent reviews on this topic [16, 18, 56–58]. Taking into consider-
ation the controversies regarding various species, in this Chapter we will focus only 
on those inconsistencies that directly relate to the topic of humans and mammalians 
aging mechanism. Animals are often used for modeling of aging mechanisms 
[59–62]. We shall discuss the following most important for MFRTA facts, which 
undermine this theory.
3.1 MtDNA are protected from the direct effects of reactive oxygen species
Recently, it has been established that neither of the above listed ROS and 
biologically active molecules are capable to cause directly mutations of mtDNA, 
which was and still is for many researchers the main hallmark of the aging process 
and it is considered as the main pathogenic mechanism of many diseases [30–33]. 
From the beginning of free radical theory of aging, mutations of mtDNA were the 
only reliable markers of oxidative stress. As a matter of fact, the MFRTA itself arose 
on the basis that changes in the production of ROS were always accompanied by 
parallel changes in the number of mtDNA mutations [13, 14, 25]. Recently, however, 
it was concluded that there was no reliable evidence for the direct involvement of 
ROS in mtDNA mutations [31, 57]. There are two main reasons for this conclusion. 
First, the commonly studied radicals are not active enough to cause mutations [55]. 
Secondly, mtDNA are encased into a protein coating of nucleoid, which prevents 
direct contact of mtDNA and radicals [31].
3.2 Antioxidant supplementation interventions do not increase longevity
Antioxidant supplementation interventions do not increase longevity, as would 
be predicted by the MFRTA. This Antioxidant Paradox is considered as the strongest 
evidence against the MFRTA; it comes from studies that manipulate antioxidant 
levels. Many studies have shown that administration of low-molecular weight anti-
oxidants failed to extend longevity [reviewed in 16, 56, 57, 63]. Barja (2014) sug-
gested that the lack of antioxidants to exert effects on longevity could be explained 
by the spatial separation: a free radical, which causes aging, acts in the lipid phase 
of membranes, while antioxidants exerts their effects mostly in the water phase of 
cells [16]. Barja (2014) also summarized the numerous studies of life longevities on 
various species: “Only two parameters currently correlate with species longevity 
in the right sense: the mitochondrial rate of reactive oxygen species (mitoROS) 
production and the degree of fatty acid unsaturation of tissue membranes” [16]. As 
we will see, these are very correct suggestions.
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3.3 The rate of O2
• production controls lifespan independently of SOD
Muller (2000) has stressed that SOD activity interspecies variation is not 
correlated with the maximal life span (MLSP) in mammals and the activity of 
other antioxidant enzymes negatively correlates with MLSP. However, there is a 
strong negative correlation between longevity and the O2
• and H2O2 production 
rates by isolated mitochondria from diverse mammalian species. The longev-
ity depends not on the amount of superoxide in a cell, but on the rate of its 
production [18]. To explain this unexpected observation, Muller suggested that 
a significant fraction (between 10% and 50%) of O2
• is not produced as aque-
ous O2
• but instead is produced as lipid-phase HO2
• in the inner mitochondrial 
membrane. In other words, Muller has proposed that it is not the O2
• in the water 
phase, but its protonated form - hydroperoxyl radical (HO2
•) in the membrane 
lipid phase exerts damaging effects on longevity, where the radical cannot be 
affected by a superoxide dismutase. Muller suggested that hydroperoxyl radical 
may initiate lipid peroxidation and the formation of peroxynitrous acid [18]. 
Unfortunately, the proposal that the hydroperoxyl radical is the aging main 
cause remained unnoticed for the next two decades, as well as the earlier similar 
attempts of other researchers before Muller [48, 63].
4. Hydroperoxyl radical HO2
• as the systemic aging cause
Here we present in brief our current views on the mechanisms of the hydroper-
oxyl radical formation and its damaging effects, which we consider as the systemic 
aging main mechanism. The details of the mechanism are presented in recent 
publications [55, 64–67].
5. Properties of the hydroperoxyl radical or perhydroxyl radical (•HО2)
Lipid phase of the mitochondrial membrane has 4–5 fold higher concentra-
tion of oxygen than the cells’ water in the cytosol. When O2 acquires an electron 
from the respiratory chain and becomes O2
•, it must quickly leave the lipid phase 
of the membrane. However, before O2
• riches the bulk of the matrix or cytosol, 
it crosses the thing layer of the structured water near the charged surfaces of 
the membrane. The inner leaflet of the inner mitochondrial membrane contains 
approximately 80–90% of total cardiolipin (CL), which, together with phosphati-
dylethanolamine (PEA), accommodate respiratory complexes and ATP-synthase 
into the mitochondrial cristae sharp curves [67]. Since CL bears strong negative 
charge, at some arears of the inner membrane aggregates of CL form areas with 
strong negative charge, called antennae, which attract protons [reviewed in 66, 
68]. For this reason, the thin layer of structured water near the charged surfaces 
of the inner mitochondrial membrane has up to three units more acid pH than 
the bulk of a compartment. This is a very important issue, because 1000 times 
higher concentration of H+ increases the probability of the hydroperoxyl radical 
formation in the O2
• + H+ ↔ •HО2 reversible reaction (pKα of the reaction is 4.8) 
[68]. Highly hydrophobic •HО2 returns back into the membrane’s lipid phase. The 
described mechanism explains why the aging process depends only on the rate 
of superoxide formation, but not on the concentration of O2
• and the activities of 
SODs. Hydroperoxyl radical is a much stronger oxidizing agent than superoxide 
radical, and has a specific propensity to abstract H atoms from α-tocopherol and, 
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particularly, from the polyunsaturated fatty acids, such as arachidonic acid (C20:4 
n6) and docosahexaenoic acid (C22:6 n3) [69].
For unknown reason, the perhydroxyl radical for a long time was almost 
completely excluded from the oxidative stress literature [61, 70]. Mitchell (2000) 
proposed perhydroxyl radical damaging mechanism through formation of per-
oxynitrite radical in the membrane [18]. This possible situation has been discussed 
by Gebicki and Bielski [69]. These authors indicated that although both •NO and 
•HО2 аre hydrophobic radicals, the radicals are spatially separated since 
•NO is 
normally present in the blood vessel endothelium, and thus the mitochondrial 
hydroperoxyl radicals have little chance to meet nitric oxide, and even if this might 
happen, the negatively charged ONOO− hardly could be a systemic damaging factor 
because it is immediately excluded from the membrane’s lipid phase [69]. Bielski 
et al. (1983) studied reactions of •HО2 with linoleic (C18:2), linolenic (C18:3) and 
arachidonic acids (C20:4) in water/ethanol solutions [68]. The obtained kinetic 
parameters of the reactions indicate that •HО2 reacts with the double allyl hydrogens 
of polyunsaturated fatty acids, and the more double bonds was present in a PUFA, 
the more active was the reaction. The abstraction of H atoms by •HО2 was exother-
mic, which indicates that it is irreversible and highly probable, when •HО2 encoun-
ters a PUFA. Since the reactions were performed in the water/ethanol solution, H2O2 
formed cleaved heterolytically (2H2O2 → H2O + O2), and the final products of the 
fatty acids with •HО2 reactions were stable hydroperoxides without much variation 
in their structure [68].
6. The isoprostane pathway of lipid peroxidation (IPLP)
When •HО2 reacts inside the lipid phase of the membrane with a PUFA, which 
is still part of a phospholipid, the products are a racemic mixture of a very large 
number of various stereo- and positional isomers [71]. Many of these products are 
similar to enzymatically produced prostaglandins, and were named Isoprostanes 
(IsoPs). For this reason, this type of PUFA autoxidation was named the Isoprostane 
Pathway of Lipid Peroxidation (IPLP) [71–73]. IsoPs possess potent biological activ-
ity and thus may convey abnormal cellular signaling and inflammation [71, 74]. 
Furthermore, many products of IPLP are very toxic, such as γ-ketoaldehydes. They 
form adducts with primary amines of the lysine-containing proteins and phospha-
tidylethanolamine (PEA). The most active among γ-ketoaldehydes are isolevug-
landins (IsoLG) produced from arachidonic acid can be only detected as adducts 
with proteins or ethanolamine of PEA [74]. In addition to arachidonic acid the most 
common PUFA among phospholipids, other PUFA such as eicosapentaenoic acid 
(20:5 n3) and docosahexaenoic acid (22:6 n3), have been found as substrates for 
the IPLP [75]. Because docosahexaenoic acid (DHA) is present in a larger quantity 
in neurons, the products of IPLP were correspondingly named neuroprostanes and 
neuroketals. From arachidonic acid, which has four double bonds, the racemic mix-
ture may contain up to eight hundreds of different products, whereas the products 
number from the containing 6 double bonds docosahexaenoic acid may be more 
than one thousand [71–73].
IsoPs and the cyclooxygenase derived prostaglandins (PGs) have a number 
of distinctions in their origin and properties, which have been discussed in a 
number of publications [65, 71, 76, 77]. Here we briefly list the most important 
distinctions: 1) The side chains of normal PGs are almost always oriented trans 
to the prostane ring whereas the products of IPLP have mostly the side chains 
with cis orientation [71, 76]; 2) The IsoPs are formed in situ from PUFA, which 
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are esterified to phospholipids, while PGs are generated exclusively from the free 
AA and DHA [77]. 3) The products of IPLP are the racemic mixture of molecules 
with a very large number of possible stereo- and positional isomers, whereas the 
products of the enzymatically produced prostaglandins have mainly one optical 
isomer [71, 76].
Figure 1A very schematically presents the pathways of arachidonic acid oxida-
tion, and Figure 1B illustrates the suggested mechanism of AA oxidation by •HО2 
[65]. The key event after abstraction of the first H atom is that H2O2 formed under 
hydrophobic condition undergoes homolytic cleavage with formation of two 
molecules of the hydroxyl radicals H2O2 → 2 
•OH, which instantly subtract another 
two H atoms from the same PUFA with formation of two molecules of H2O. The 
remaining molecule of the AA has completely disarranged double bonds, becomes 
extremely unstable and quickly attaches randomly two O2 molecules, and undergoes 
intramolecular transitions with formation of one out of many possible positional 
and stereoisomers. Thus •HO2 converts into 2 H2O and AA loses two out of 4 double 
bonds, and becomes one of hundreds isoprostanes. The differences between IPLP 
and the “classical” lipid peroxidation have been discussed in [65, 79].
Figure 1. 
Autoxidation of arachidonic acid with transformation of the molecule into various ring structures.  
(A) this part of the figure was adapted from the article [78] and shows different intermediary metabolites 
during autoxidation of arachidonic acid (AA). HO2
• is the only candidate for initiation of the isoprostane 
autoxidation of PUFA [65]. (B) the suggested sequence of transformations of HO2
• and AA in the course of 
isoprostane lipid peroxidation (IPLP) [65]. After abstraction of the first H atom from a molecule of AA, HO2
• 
turns into H2O2, which in the hydrophobic milieu undergoes homolytic cleavage into two molecules of 
•OH 
radicals, which instantly subtract the next two H atoms from the AA with formation of two molecules of H2O 
and the remains of the AA has completely disarranged double bonds. A very fast abstraction of three H atoms 
from any of the four double bonds leads to the fact that the residue of the AA becomes extremely unstable and 
quickly attaches two O2 molecules in a random way and undergoes intramolecular transitions with formation 
of one out of many possible positional and stereoisomers. The more PUFA has double bonds, the more possible 
isomers for the end product of the reaction. Abbreviations: F2-IsoP, E2-IsoP, D2-IsoP – Isoprostanes with, 
correspondingly, prostane rings F2, E2, D2 or A2 and J2; IsoTxA2 and IsoTxB2 – Isothromboxanes with rings  
A2 и B2, correspondingly, which were formed from prostaglandins H2 (PGH2); E2-IsoK и D2-IsoK – Isoketals 
with rings E2 и D2.
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7. IPLP as the mechanism of aging
It has been demonstrated by researchers from the Vanderbilt University that 
IsoPs are the most early and reliable markers of lipid peroxidation in vivo, and 
recent studies provided valuable information about participation of IPLP in patho-
genesis of numerous human diseases [80–82]. According to our model of IPLP 
initiation by HO2
•, the hydroperoxyl radical upon encounter with a PUFA produces 
one of many variants of isoPG, γ-ketoaldehyde or isolevuglandins. When reacting 
with fatty acids with two unsaturated bonds, such as linoleic acids of cardiolipin, 
HO2
• produces corresponding hydroperoxides.
The different toxic products of the IPLP evidently cause numerous and differ-
ent lesions to mitochondria gradually causing wear and tear of mitochondrial and 
cellular functions. We distinguish two types of direct lesions to mitochondria: one 
dysfunctions type is caused by oxidation of CL and PEA, which result in structural 
changes of respirosomes and ATP-synthase complexes. The second dysfunctions 
type is caused by direct damages by toxic products, like isolevuglandins, which 
directly form adducts with PEA and lysine of proteins. This type of damages may 
explain mtDNA replication damages [33, 34, 83]. Anderson et al. [83] have shown 
that mtDNA replicase exo domain, Pol gamma, is far more sensitive to oxidation 
than pol domain. The authors suggested that under oxidative conditions, exonucle-
ase activity therefore declines more rapidly than polymerase. The oxidized Pol 
gamma becomes editing-deficient, displaying a 20-fold elevated mutations than 
the unoxidized enzyme [83]. PEA may be damaged by both pathways: via PUFA 
at C2 autoxidation, and via formation of adducts of ethanolamine with IsoLG 
produced upon activation if IPLP by HO2
•. Of note, most of the ROS have very 
short lifetime (seconds) but IsoLG produce rather stable adducts (lifetime days), 
which can accumulate with age and, therefore, contribute to the development of 
age-associated conditions.
8.  The importance of fatty acids oxidation for increased rate of ROS 
production
Mammalian tissues mitochondria generate superoxide and hydrogen peroxide 
(ROS) from 11 different sites depending on substrates used and the redox state 
of the electron transport chain [21]. All mitochondrial ROS production sites have 
distinct properties [21, 84]. They can be divided into two groups: six sites operate 
at the redox potential of the NADH/NAD+ isopotential pool, about −280 mV, and 
five sites operate at the redox potential of the ubiquinol/ubiquinone (QH2/Q ) 
isopotential pool, about +20 mV [21, 84].
Much of the published literature on contribution of separate respiratory com-
plexes in generation of ROS have potential problems for several reasons: first, the 
authors often used inhibitors of the respiratory chain, which is far from situation 
in situ, secondly, most authors used a single substrate, whereas in situ mitochondria 
metabolize several substrates simultaneously [85–88]. Most importantly and, with 
few exceptions, authors never used fatty acids as substrates for mitochondrial 
respiration. Brandt and colleagues provided evidence that the highest rates of ROS 
production (O2
• + H2O2) are observed during β-oxidation of fatty acids [21, 84, 89]. 
During β-oxidation of fatty acids the membrane’s pool of CoQ becomes fully reduced 
to CoQH2 and this may reverse the transport of reducing equivalents at the level of 
succinate dehydrogenase (SDH), also known as Complex II, and thus activate the 
reverse electron transport and involve the sites of respiratory Complexes I and III, 
and SDH (Complex II) in production of ROS [21, 89].
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It has been recently shown that active oxidation of palmitoyl-carnitine by 
mitochondria in all metabolic states absolutely requires the simultaneous presence 
of any of the other mitochondrial metabolites such as: pyruvate, succinate, malate 
or glutamate, which were designated as “fatty acid oxidation supporting substrates” 
[87, 88]. In the presence of supporting substrates, fatty acids are actively oxidized 
not only by the isolated heart mitochondria [88], but also by the brain synaptic 
mitochondria [87], which breaks the old myth that the brain’s energy metabolism is 
supported almost exclusively by glucose [reviewed in 87].
Most importantly, active oxidation of fatty acids in the presence of supporting 
substrates results in a manifold increase in ROS production in resting mitochondria 
(Figure 2). Earlier, we have proposed that oxidative damages and thus accelerated 
aging, are more common for organs, which have a wide range of physiological 
activities, such as heart, skeletal muscles and brain [65, 88]. When these organs are 
at low workloads or at rest, the very efficient oxidation of fatty acids may redirect 
excessive electrons to generation of ROS.
9. OK, MRFTA is valid, but what is aging?
In the sections above, we presented evidence that in spite of complications of the 
MFRTA based on old paradigms, the latest discoveries clearly support the essence 
of this theory, and the introduction of the perhydroxyl radical as a new mediator of 
oxidative stress resolve most of the contradictions. However, MFRTA still requires 
further consideration and we have to find answers to simple questions: what is aging 
and when the aging begins?
From the beginning, researchers working on MFRTA held the point of view that 
aging is a pathological process caused by oxidative stress that affects our health, and 
over time, we succumb to a myriad of age-related pathologies and eventually die 
[12, 58]. But is aging simply the process of errors accumulation? The Dictionary of 
Science and Technology designates aging as “the process of growing older or chang-
ing over time” [90]. In other words, a person after birth goes through a series of 
genetically controlled transitions, which are called postembryonic ontogenesis [91]. 
From the point of view of a human ontogeny, we can roughly divide a person’s indi-
vidual life into five periods: infancy, childhood, adolescence, reproductive period 
and post-reproductive, or aging period. For several reasons, we hardly expect that 
during infancy, childhood and adolescence “a myriad of age-related pathologies” 
Figure 2. 
Production of superoxide radicals by rat heart mitochondria oxidizing palmitoyl-carnitine. Designations: 
1. Supporting substrate only; 2. Palmitoyl-carnitine only, and 3. Palmitoyl-carnitine + supporting substrate. 
Substrates: Figure 2A - pyruvate 2.5 mM + malate 2 mM, Figure 2B - glutamate 5 mM + malate 2 mM, 
and Figure 2C. – Succinate 5 mM. Experimental conditions are described in [88]. The incubation medium 
contained: Amplex red 2 μM, horse radish peroxidase 2 units, substrates as indicated above, volume 1 ml. The 
reaction was initiated by addition of 50 μg of mitochondria. Initial rates were measured for 3 minutes. Numbers 
at the traces are the rates of H2O2 production in picomol H2O2/min/mg protein RHM. The rates were corrected 
for the time control rate with RHM incubated without added substrates. The figure was taken from [88].
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might be accumulated [58]. We will consider the last two periods: “reproductive”, 
which comprises the ages from 20 to 50, and the “aging period”, which begins after 
the age of 50 [92].
Among recent definitions of aging there were few in more general terms: “Aging 
is characterized by a gradual decline in various health parameters across multiple 
biochemical, physiological and behavioral systems” [93]. Correspondingly, some 
researchers started looking for a subset of aging individuals with lack of resilience 
within these general physiological systems, a condition termed frailty. Frailty 
has been defined in broad terms as an age-associated syndrome characterized by 
increased vulnerability to external influences, a diminished capacity to respond 
correctly to stressors and as an overall loss of fitness. In general, frail individuals are 
at a greater risk of falls, dependency, disability, institutionalization, hospitaliza-
tion and mortality [94]. Frailty can be measured in relation to the accumulation 
of deficits using a frailty index. A frailty index can be developed from most aging 
databases [95, 96].
In another parallel world of Science, a large group of researchers study the meta-
bolic syndrome, a nosological entity established at the end of 80s of the last century. 
The metabolic syndrome (MetS) was defined as a condition of simultaneous 
existence of several risk factors, including obesity, insulin resistance, atherogenic 
dyslipidemia and hypertension, which are interrelated, age-dependent, and share 
underlying mediators and metabolic pathways [97]. Undoubtedly, both concepts 
of frailty and metabolic syndrome are important from a medical perspective, but 
apparently did little for understanding the mechanisms of aging. Due to intensive 
research on both concepts, however, there has been made a great discovery: the rates 
of aging and energy metabolism are sex-specific. In our opinion, these discoveries 
are crucial for understanding the mechanisms of aging as the process of transition 
of an individual from the reproduction period to the last stage of ontogeny – aging.
10. Sex-specific differences in the rates of aging and longevity
Most animals and plants are sexual, in spite of the reproductive advantages 
experienced by asexual variants. Evidently there where selective forces that gave 
an advantage to sexuality and genetic recombination at either the population or 
individual level. The effect of sex and recombination increases the efficiency of 
natural selection, which is a major factor favoring evolution [98, 99]. It has been 
experimentally shown that sex increases the rate of adaptation to a new harsh 
environment, but has no measurable effect on fitness in a new benign environment 
where there is little selection [100]. Nonetheless, we are still far from a definitive 
answer to the question of why sexual reproduction is so common [99]. Recently, 
the hypothesis has been put forward that the internal production of ROS 2 billion 
years ago started the eukaryotic sex (re)evolution [101]. It has also been stressed 
that earlier theoretical works on sexual reproduction ignored important complexi-
ties that face natural populations, such as genetic drift and the spatial structure of 
populations [102].
The data accumulated show that in many species, including humans, females 
have slower rate of aging and longer life span than males [99, 103–105]. We suggest 
that this observation has important general biological goals for a female: bear-
ing and raising a new generation despite any external difficulties and metabolic 
restrictions. These goals demand that females have to be efficient enough, but not 
superefficient from the metabolic (thermodynamic) point of view, resilient to 
harsh environmental conditions, and, in accord with the MFRTA, have lower rate of 
oxidative stress. Numerous studies of various species showed that in general females 
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have slower production of ROS than males [99]. As always, there are some exclu-
sions from the general rule, but again they hold the same conclusion: the longer 
living gender produces less ROS [106].
In the next sections we will discuss possible mechanisms underlying the slower 
aging and slower rates of ROS production in the longer living females.
11.  Sex-specific differences in the rates of fat utilization for the sake of 
energy metabolism
Laboratory animals are indispensable part of biomedical research and widely 
used for modeling physiological and pathological situations in humans [107]. 
For ethical and technical restrictions, it is impossible to study many biomedical 
problems on humans, whereas animal research provides a degree of experimental 
control and precision not usually feasible in studies using human subjects [108]. 
Meanwhile, the animals used in most experiments were males, because researchers 
usually avoid using females for the reason of their reproductive cycles and hormone 
fluctuations that may affect the results of their studies [109]. For these reasons 
research on sex differences has begun relatively recently, but today the related 
literature is enormous. Human studies on metabolic differences between men and 
women were stimulated largely due to the progress of the sport medicine. Here, 
we will discuss only those works, which have direct relation to our subject under 
discussion: what sex metabolic differences underlie the fact that females live longer 
than males in many species, including humans [108].
Evidently, the sex differences in the body structure and metabolism depend on 
the stage of a person’s ontogeny. Vijay et al. (2015) studied sexual differences in the 
expression of mitochondria-related genes in rat heart at different ages that corre-
spond to different stages of the rat’s reproductive capacities [110]. The authors stud-
ied the whole genome expression profiling in the hearts of young (8-week), adult 
(21-week), and old (78-week) male and female Fischer 344 rats, and the expression 
of 670 unique genes related to various mitochondrial functions was analyzed. A 
significant (p < 0.05) sexual dimorphism in expression was observed in young ani-
mals for 46, adult for 114 and old rats for 41 genes, respectively [110]. Importantly, 
in young and adult hearts, sexual dimorphism was not noted in genes encoding 
oxidative phosphorylation. Adult males showed higher expression of genes associ-
ated with the pyruvate dehydrogenase complex as compared to females. In old rats 
a majority of genes involved in oxidative phosphorylation had higher expression in 
females. This clearly shows that sexual dimorphism largely depends on the stage of 
ontogeny. Other studies demonstrated better preservation of myocardial mass and 
a greater cardiac contractility in women than men during aging [111]. The better 
heart health in aged women might be the result of either genetically predetermined 
factors or less oxidative damages and slower aging as compared to men.
It is a well-known observation that women generally have a higher amount of 
body fat than men. Distribution of fat is also different: women store more fat in the 
gluteal-femoral region, whereas men have more body fat in the abdominal (vis-
ceral) region [112, 113]. Importantly, that visceral fat accumulation is accompanied 
with multiple endocrine perturbations, including elevated cortisol and androgens 
in women, as well as low growth hormone and, in men, testosterone secretion. The 
consequences of the hormones effects will be more expressed in visceral than sub-
cutaneous adipose tissues, because omental fat has higher cellularity, innervation 
and blood flow. Furthermore, the density of cortisol and androgen receptors seems 
to be higher in visceral fat than in other regions of adipose tissue [114]. In addition, 
there are epidemiological and metabolic associations between centralized (visceral) 
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fat accumulation and disease [114]. This is an important fact because visceral 
obesity is a common symptom for men and women with metabolic syndrome.
Physiological experiments with oral administration of triglycerides, labeled with 
a small amount of oleic acid, revealed the following regional differences in the order 
of lipid uptake: omental = retroperitoneal > subcutaneous abdominal > subcutane-
ous femoral adipose tissues in men, with a similar rank order for half-life of the 
triglyceride, indicating also a turn-over of triglycerides in that order. Testosterone 
amplifies these differences in men. In premenopausal women, the visceral fat 
accumulation is smaller than in men, and subcutaneous abdominal has a higher 
turnover than femoral adipose tissue [114]. Among regional gender differences of 
fat metabolism, there is an interesting evidence that in vivo, catecholamine medi-
ated leg free fatty acid release is lower in women than in men, whereas free fatty 
acid release from the upper body depots is comparable [112].
These experiments in vivo indicate that sex variations in fat metabolism are 
controlled by sex-specific hormones. This presumes that in the post-reproductive 
stage of ontogenesis, the sexual dimorphism in fat metabolism should be weaker 
or absent. Results of studies in vitro also indicate that this difference is diminished 
at the menopause, and may be restored by estrogen therapy. This suggest that the 
functional effects of estrogens in women are similar to those of testosterone in 
men. As we will show in the next section, the effects of both hormones are targeted 
on substrate oxidations by mitochondria, and, thus, on the rates of ROS produc-
tion. However, the mechanism of estrogen on fat metabolism might be indirect 
because human adipose tissue does not possess specific estrogen and progesterone 
receptors [114].
As regards protein metabolism, no gender differences in the basal level net muscle 
protein balance have been found [115]. In general, testosterone increases muscle pro-
tein synthesis and net muscle protein balance, resulting in increased muscle mass. At 
young age, boys and girls have similar amounts of testosterone. At puberty testosterone 
levels increase much more dramatically in males, as does muscle mass. Furthermore, 
although no evidence exists in humans, the in-vitro and rat data suggest that ovarian 
hormones inhibit muscle protein synthesis [115].
12. Sex differences in substrate utilization during physical activities
The indirect effect of the sex hormones on fat metabolism is supported by the 
data on sexual dimorphism in utilization of fatty acids during physical activities, 
which demonstrate that the proportion of energy derived from fat during exercise is 
higher in women than in men [112, 116]. Carter et al. (2001) investigated the effect 
of endurance training on whole body substrate, glucose, and glycerol utilization 
during 90 min of exercise in males and females [116]. First, during submaximal 
physical loads females show a lower respiratory exchange ratio (RER) than males, 
which indicates on a proportionately lower carbohydrate and higher fat oxidation 
[116, 117]. In comparison with females, exercising males had a greater increase in 
leucine oxidation but not lysine levels, which indicated that during intensive physi-
cal activity males increase their need for amino acids to fuel energy needs. Under 
the same conditions, females responded by increased mobilization of fat, thereby 
requiring less alternative fuels such as carbohydrate and amino acids [116–118]. 
The overall conclusion of these experiments was that females oxidize a greater 
proportion of fat and less carbohydrates and amino acids as compared with males. 
Thus physiologists support our finding that fatty acids oxidation requires simulta-
neous presence of other mitochondrial metabolites derived from carbohydrates or 
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proteins [88]. Because women have lesser consumption of supporting substrates, 
the rate of fatty acids oxidation should be also diminished. This might explain why, 
in general, women demonstrate lower levels of physical performance during endur-
ance sports and produce less ROS [119–121].
Knowing the fact that mitochondria oxidize fatty acids only in the pres-
ence of supporting substrates [87, 88], the data presented above suggest that 
females require less or different supporting substrates for effective oxidation of 
fatty acids. We can, therefore, predict that the isolated skeletal muscle or heart 
mitochondria from females must be different from males in terms of the type 
and requirement of supporting substrates, and also produce ROS at a slower 
rate. Unfortunately, until now we have been the only ones who have studied the 
oxidation of fatty acids in the presence of various supporting substrates, but we 
used male rats only in our experiments [87, 88]. Figure 3 illustrates that the rates 
of ROS production strongly depend on the type of supporting substrates, namely 
pyruvate, glutamate and succinate, and their various mixtures [55, 87, 88]. Thus 
the in vitro experiments with the isolated mitochondria from different organs 
require further investigation in order to elucidate molecular mechanisms of the 
sex diversity at the mitochondrial level. Since males showed higher expression 
of genes associated with the pyruvate dehydrogenase complex, as compared to 
females [111], and consume more carbohydrates and amino acids during endur-
ance training [116–118] we can suggest that women’s higher longevity and slower 
rate of aging is associated with the less efficient oxidation of fatty acids and 
thus slower rates of oxidative stress. However, this conclusion evidently regards 
only women at the reproductive stage, when, according to Ventura-Clapier et al. 
(2020), women are “protected” [122]. These authors also stated that “apart from 
comparisons between males and females, there is a crucial need for studying 
the female physiology and woman pathology. In particular the biological step 
that constitutes menopause in women appears to be the border between “female 
protection” and “female susceptibility” to cardiovascular diseases, which needs to 
be deciphered further”.
Figure 3. 
Effect of substrate mixtures on production of ROS by isolated rat heart mitochondria oxidizing  
palmitoyl-carnitine. The incubation medium contained: Amplex red 2 μM, horse radish peroxidase 2 units, 
volume 1 ml. The reaction was initiated by addition of 50 μg of mitochondria. Initial rates were measured 
for 3 minutes. Substrates: 1. Succinate 5 mM; 2. Succinate + pyruvate 2.5 mM + glutamate 5 mM + malate 
2 mM; 3. Palmitoyl-carnitine 50 μM + succinate; 4. Palmitoyl-carnitine + succinate + pyruvate + glutamate + 
malate. Numbers at the traces are the rates of H2O2 production in picomol H2O2/min/mg protein RHM. The 




13.  Metabolic syndrome (MetS) as the post-reproductive stage of 
ontogenesis
Long time ago physicians noticed that many patients have common features 
of external appearances and biochemical indices of abnormal metabolism, which 
included insulin resistance, obesity, atherogenic dyslipidemia and hypertension. 
By the end of 80s of the 20th century the term “Metabolic syndrome” has been 
accepted and its own diagnostic code: 277.7 has been assigned by the International 
Classification, 9th Division, Clinical Modification (ICD-9-CM). However, the 
current definitions of the metabolic syndrome (MetS) give no clues to the essence 
of MetS and are mostly just listings of symptoms, for example: “The metabolic 
syndrome is a constellation of metabolic disorders including obesity, hypertension, 
and insulin resistance, components, which are risk factors for the development 
of diabetes, hypertension, cardiovascular, and renal disease” [123, 124]. This 
“clustering” or “constellation” of risk factors were considered to share underlying 
causes, mechanisms and features. The diagnosis of MetS is accepted only when 
at least three out of five symptoms are present in a patient [125, 126]. It was early 
recognized that people with isolated components, but who do not fit the defini-
tion of metabolic syndrome, are not at as high a risk for type 2 diabetes (T2D) or 
cardiovascular diseases (CVD). For example, people with isolated hypertension or 
isolated hyperlipidemia are at risk of CVD, or people with isolated obesity are at risk 
for T2D, but less so than people who meet multiple criteria of MetS [123].
It was expected that a comprehensive definition for the metabolic syndrome and 
its key features will facilitate research into its causes and lead to pharmacologic and 
lifestyle treatment approaches [127]. However, analysis of the tremendous amount 
of publications regarding MetS revealed that more than 30 years after defining 
MetS, there is still no deep understanding how and why MetS develops. Much of 
the literature can be roughly divided into supporters and opponents of considering 
insulin resistance as the primary symptom for the diagnosing MetS [123, 128–130]. 
These discrepancies were reflected in the criteria for diagnosing MetS provided 
by several Institutions, which were thoroughly reviewed in [123]. The discussions 
become heated by publications that ethnic and racial factors may greatly affect the 
criteria for diagnosis of MetS [127, 131].
14. The origin of MetS
The results of genetics studies on the potential hereditary predisposition to MetS 
were analyzed by Stančakova and Laakso [132]. They concluded that there is only a 
limited evidence for common genetic background explaining the clustering of the 
metabolic trait. Instead, the existing evidence suggests the importance of epigenetic 
mechanisms [132]. This conclusion supports our earlier suggestion [55, 66, 67] that 
the external appearances and metabolic features of MetS reflect the genetic proper-
ties of our distant ancestors. So far, however, aging and MetS have been commonly 
regarded as the result of accumulation of different kinds of damages caused by 
oxidative stress and/or improper life style [8–11, 133–135].
As we have stressed earlier, all human beings after birth undergo changes 
during postembryonic ontogenesis. One of the theories of aging suggests that with 
the advanced age, the loss of heterochromatin results in altered gene expression 
[1, 2]. The epigenetic alterations resulting from global heterochromatin loss may 
be at the root of the various molecular events associated with aging and may tie 
together the various models of aging [2]. However, the process of ontogenesis in 
humans suggests that each transition to a new stage switches conversion of a new 
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portion of heterochromatin into euchromatin, and new genes begin to work, and 
then during transition to a the next stage, the “previous” portion of euchromatin 
does not turn back into heterochromatin, but becomes lost. Therefore, the so 
called “general loss” of the heterochromatin with advancing age simply reflects 
the advancement of individual ontogeny. Evidently, when men and women enter 
the post-reproductive stage of ontogenesis, they have lost much of the hetero-
chromatin that was present in a newborn baby. The genes that govern the post-
reproductive stage were not the subject for natural selection, and therefore they 
are the same, or almost the same, genes that our distant ancestors had. This can be 
proved by many qualities in our bodies that appear after the age of 55: bulky body 
structure, dark spots of myelin in the skin, hair distribution, etc. Evidently, after 
transition to the post-reproductive stage many metabolic features also become 
distinct from the previous stages. There is a lot of evidence that elderly people of 
the northern Europe and Siberia acquire external and metabolic features common 
to the people living in the Northern Polar Regions. Inhabitants of the North, for 
example Eskimos, Dolgans, Innuits, do not consume a lot of plant foods rich in 
carbohydrates. Their diet is based on meat, animal fat and fish.
Again, the clue to understanding the nature of MetS, we can find in the sex asso-
ciated differences in the energy metabolism and the transition of men and women 
from reproductive to the post-reproductive stage of ontogenesis, which is com-
monly regarded as the stage of aging [92]. This usually occurs between the ages of 
50 and 55, when women go through menopause. The sharp changes in appearance 
and metabolism are particularly evident in women during and after the menopause, 
which increases the risk of MetS by 60% [136]. It is important, that the occurrence 
of MetS in the post-menopause period does not depend on the body mass index 
(BMD) and physical activity [137], but may depend in women on the dynamics of 
estrogen decline with age [138]. Interestingly, studies on sex hormone replacement 
in animals have shown that males receiving testosterone showed MetS deteriora-
tion, while females with estrogen replacement showed improvement in their MetS 
symptoms such as decreased hypertension [139]. This agrees with the suggestion 
that the genetically predetermined transition to the post-reproductive stage during 
normal ontogenesis, which is accompanied by changes in the hormone status, is 
the major natural cause of MetS. Thus some features of MetS, namely insensitivity 
to insulin and gain of fat, particularly visceral obesity, simply reflect a new type of 
metabolism. From this point of view, T2D may result from the excessive consump-
tion of unnecessary carbohydrates at the post-reproductive stage.
15.  Sex differences in the transition from reproductive to  
post-reproductive stage
In one of the previous sections we provided evidence that women oxidize fatty 
acids, which are the predominant energy source at all ages, at a slower rate in 
comparison with men, and thus probably produce ROS at a slower rate [116–118]. 
Olivetty et all. [111] studied changes in mononucleated and binucleated myocytes 
with age in enzymatically dissociated cells. The age interval examined varied from 
17 to 95 years. The authors have found that in the course of aging women’s hearts 
preserved the ventricular myocardial mass, aggregate number of mononucleated 
and binucleated myocytes, average cell diameter and volume. In contrast, in the 
men’s hearts the authors observed nearly 1 g/year loss of myocardium, and this 
phenomenon accounted for the loss of approximately 64 million cells. These detri-
mental events involved the whole male’s heart. In the remaining cells, myocyte cell 
volume increased at a rate of 158 microns3/year in the left and 167 microns3/year 
Update in Geriatrics
18
in the right ventricle. And these changes in the men’s hearts were linear from the 
age of 17 to 95, whereas in women the structural properties of the heart remained 
unchanged [111]. Thus, it seems that women enter the post-reproductive stage 
with relatively “young” heart, whereas in men the aged heart lost many cells and 
the remaining cells increased their volume, which is a disadvantage for the heart’s 
energy metabolism.
16.  Features of fatty acids metabolism that increase MetS symptoms and 
accelerate aging
Among mammalians the human females have a unique duration of post-
reproductive longevity [140], which is probably to a large degree associated with the 
metabolic “protection” that caused slower rate of aging at the reproductive period 
[122]. There are several reasons to argue that both the accelerated rate of aging 
of men and the relatively slow aging of women, as well as other sex differences in 
metabolism and physical performance, are based on the sex differences in fatty 
acids metabolism. Regardless of age and gender, fats are the major source of energy, 
carbon and hydrogen for the anaplerotic reactions. Table 1 shows the relative 
amounts and times of consumption of the three main sources of mitochondrial 
substrates for obtaining energy and intermediary metabolites for the growth and 
maintenance of the body.
Table 1 shows that carbohydrates stores are small and must be constantly 
replenished by gluconeogenesis in the liver. Amino acids reserves are practically 
absent and they are constantly formed due to the digestion of food proteins, as 
well as in anaplerotic reactions in mitochondria. Carbohydrates are too precious 
to be used for obtaining energy. Much of glucose, particularly at young age, is 
used for the synthesis of RNA and DNA, purine and pyrimidine nucleotides. Only 
erythrocytes, which have no mitochondria utilize glucose for obtaining ATP by 
glycolysis and NADPH for reducing glutathione. There is an old myth that brain 
consumes only glucose for supporting its energy needs. However, most of the 
lactate and neuromediators glutamate and γ-aminobutyric acid, which are also used 
by synaptic mitochondria as energy substrates, are synthesized by the astrocytes 
from the carbon atoms of fatty acids and for the expense of energy derived during 








Total 4–5 grams (20–30 min)
100–120 gram (1–3 hrs.)
Released during catabolism of food, damaged tissue proteins 
and anaplerotic reactions. The content is highly dynamic.
Fat (Kilograms) days
Table 1. 
It is shown that carbohydrates stores are small and must be constantly replenished by gluconeogenesis in the 
liver. Amino acids reserves are practically absent and they are constantly formed due to the digestion of food 
proteins, as well as in anaplerotic reactions in mitochondria. Carbohydrates are too precious to be used for 
obtaining energy. Much of glucose, particularly at young age, is used for the synthesis of RNA and DNA, purine 
and pyrimidine nucleotides. Only erythrocytes, which have no mitochondria utilize glucose for obtaining ATP 
by glycolysis and NADPH for reducing glutathione. There is an old myth that brain consumes only glucose for 
supporting its energy needs. However, most of the lactate and neuromediators glutamate and γ-aminobutyric 
acid, which are also used by synaptic mitochondria as energy substrates, are synthesized by the astrocytes from 
the carbon atoms of fatty acids and for expense of energy derived during β-oxidation of fatty acids. Synaptic 
mitochondria also gladly oxidize fatty acids in the presence of supporting substrates [85, 87].
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β-oxidation of fatty acids. Synaptic mitochondria also gladly oxidize fatty acids in 
the presence of supporting substrates [85, 87].
The energetic efficiency of β-oxidation of fatty acids in the presence of support-
ing substrates is the only combination of substrates capable to support the highest 
rates of oxidative phosphorylation in the heart during maximal physical loads. The 
efficiency is achieved by the reduction of not only NADH/NAD+ system in mito-
chondria, but also by reduction of the membrane pool of ubiquinol/ubiquinone. 
Therefore, during β-oxidation of fatty acids, electrons enter the respiratory chain 
not only from Complex I, but mainly through complexes II and III. However, when 
the energy demands by the organ’s functions diminish, the excess of energy in mito-
chondria may redirect electrons for production of the superoxide radicals, and thus 
HO2
• [66, 88]. Oxidation by mitochondria of the NAD-dependent substrates cannot 
provide high rates of ATP and ROS production because NADH-dehydrogenase 
activity of Complex I is the rate limiting step [141].
Brandt [21] observed that the rate of ROS production may be increased, when 
mitochondria have abundant supply of substrates and low level of ATP consump-
tion (low functional load), and diminish when consumption of energy is high, or 
the substrate supply is limiting. This explains why the symptoms of MetS strongly 
depend on the life style. This is probably the main reason why men start aging faster 
and earlier then women. At the age of 45–50, many men reduce physical activity, eat 
too much and abuse alcohol, which dramatically accelerates ROS production.
After menopause, the women’s hormonal status becomes closer to that of men, 
and therefore they also must utilize fatty acids as the main substrates for energy 
production. At the post-reproductive stage of ontogenesis, we can assume that both 
men and women have metabolic pattern similar to their distant ancestors, who did 
not consume a lot of carbohydrates. This may explain the origin of the insulin resis-
tance at MetS. This is not a pathology rather than a new physiological reality due to 
metabolic reprogramming at the post-reproductive stage. With low insulin sensitiv-
ity, most consumed carbohydrates are directed to the synthesis of lipids, which 
accelerates obesity, first of all visceral obesity. Excessive food consumption plus 
lower physical and mental activities accelerate production of superoxide radicals, 
and, thus, perhydroxyl radicals. This accelerates IPLP yielding harmful products, 
which have proinflammatory activities, cause damages to proteins, cardiolipin and 
PEA resulting in mitochondrial dysfunctions and accelerating aging.
For a long time, these gradually accumulating various functional disorders and 
structural damages are not accompanied by specific clinical manifestations. In 
people predisposed to an earlier aging, the clinical symptoms may be unspecific and 
look like frailty. With time, the accumulated wear and tear will cause development 
of clinical symptoms, like acute heart failure, Alzheimer’s disease, or something 
else, and finally death.
Literature show diminished fatty acids oxidation and developments of MetS 
symptoms in the females without estrogen that can be normalized by administra-
tion of estrogen [142, 143]. We do not think that those publications contradict to 
our conclusions presented in this Chapter, because those experiments have been 
done on young animals 7–8 weeks old.
17. Conclusions
In this Chapter we have presented evidence that activation of IPLP by hydro-
peroxyl radical, protonated form of superoxide radical, provides explanation to 
the slow and inevitable mechanism of aging and resolves many objections against 
MFRTA in the current paradigms. We also have shown that focusing only on the 
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damages, which accompany aging, is not very helpful, because it gives no answers 
on why and when aging actually starts, and why women age slower and live longer 
than men. We have explained the idea that aging is, first of all, the process of 
development in time, when men and women go through a number of genetically 
predetermined stages. Because men and women have different biological roles, 
they also have different metabolic strategies. Fatty acids at all stages of ontogeny 
are the main substrates for provision of energy and intermediate metabolites for 
the growth and maintenance. The energetic efficiency of β-oxidation of fatty acids 
is controlled by the type of mitochondrial metabolites that oxidize simultaneously 
with fatty acids. However, this results in a significant increase in oxidative stress. 
We suggest that sex hormones determine the type and quantity of supporting 
substrates, which result in different rates of energy production and oxidative stress. 
Women consume more fatty acids with lower efficiency, and thus age at a slower 
pace. When men and women enter the post-reproductive stage of the ontogeny, the 
type of metabolism also changes because this last stage of ontogeny is controlled by 
ancient genes of our distant predecessors. In Figure 4 we summarized the available 
information as a scheme, which shows the approximate differences between men 
and women in ROS production during ontogeny. The metabolic syndrome, which 
usually begin developing after the age of 45 in men and 55 in women, reflects two 
main events: the transition to the post-reproductive stage of ontogeny, and the new 
type of metabolism. Because fatty acids become the major substrates for the energy 
production in all organs, the rate of ROS production, and, consequently, the rate of 
aging may increase dramatically. The specific symptoms of the MetS prevailing in 
particular individuals will depend on the genetic background of their ancestors and 
the life style.
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